| ASSET | % RETURN |
|---|---|
AXT (AXTI) | 5,702.13% |
Kodiak Sciences (KOD) | 2,137.73% |
Tango Therapeutics (TNGX) | 1,738.35% |
Abivax SA American Depositary Shares (ABVX) | 1,215.35% |
Aehr Test Systems (AEHR) | 1,071.86% |
Erasca (ERAS) | 905.52% |
Ondas (ONDS) | 812.82% |
MaxLinear (MXL) | 794.37% |
Applied Opt (AAOI) | 701.49% |
Oruka Therapeutics (ORKA) | 676% |
Praxis Precision Medicines (PRAX) | 666.32% |
ViaSat (VSAT) | 654.02% |
Sellas Life Sciences (SLS) | 606.36% |
Celcuity LLC (CELC) | 573.81% |
Navitas Semiconductor (NVTS) | 524.74% |
Cogent Biosciences (COGT) | 505.17% |
Par Pacific (PARR) | 498.68% |
Delek US Energy (DK) | 495.97% |
Spyre Therapeutics (SYRE) | 491.64% |
Definium Therapeutics (DFTX) | 488.42% |
Silicon Motion Technology (SIMO) | 466.93% |
Relay Therapeutics (RLAY) | 456.93% |
Amylyx Pharmaceuticals (AMLX) | 449.51% |
MBX Biosciences, Inc Common Stock (MBX) | 437.04% |
Abcellera Biologics (ABCL) | 435% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.